Show simple item record

dc.contributor.authorSamy, R.
dc.contributor.authorThwin, M.
dc.contributor.authorStiles, B.
dc.contributor.authorSatyanarayana-Jois, S.
dc.contributor.authorChinnathambi, A.
dc.contributor.authorZayed, M.
dc.contributor.authorAlharbi, S.
dc.contributor.authorSiveen, K.
dc.contributor.authorSikka, S.
dc.contributor.authorKumar, Alan Prem
dc.contributor.authorSethi, G.
dc.contributor.authorLim, L.
dc.date.accessioned2017-01-30T13:03:25Z
dc.date.available2017-01-30T13:03:25Z
dc.date.created2016-01-12T20:00:21Z
dc.date.issued2015
dc.identifier.citationSamy, R. and Thwin, M. and Stiles, B. and Satyanarayana-Jois, S. and Chinnathambi, A. and Zayed, M. and Alharbi, S. et al. 2015. Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics. Biochimie. 111: pp. 30-44.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/28144
dc.identifier.doi10.1016/j.biochi.2015.01.003
dc.description.abstract

Antimicrobial peptides (AMPs) play a vital role in defense against resistant bacteria. In this study, eight different AMPs synthesized from Python reticulatus serum protein were tested for bactericidal activity against various Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Burkholderia pseudomallei (KHW and TES strains), and Proteus vulgaris) using a disc-diffusion method (20 µg/disc). Among the tested peptides, phospholipase A2 inhibitory peptide (PIP)-18[59-76], ß-Asp65-PIP[59-67], D-Ala66-PNT.II, and D60,65E-PIP[59-67] displayed the most potent bactericidal activity against all tested pathogens in a dose-dependent manner (100-6.8 µg/ml), with a remarkable activity noted against S. aureus at 6.8 µg/ml dose within 6 h of incubation. Determination of minimum inhibitory concentrations (MICs) by a micro-broth dilution method at 100-3.125 µg/ml revealed that PIP-18[59-76], ß-Asp65-PIP[59-67] and D-Ala66-PNT.II peptides exerted a potent inhibitory effect against S. aureus and B. pseudomallei (KHW) (MICs 3.125 µg/ml), while a much less inhibitory potency (MICs 12.5 µg/ml) was noted for ß-Asp65-PIP[59-67] and D-Ala66-PNT.II peptides against B. pseudomallei (TES). Higher doses of peptides had no effect on the other two strains (i.e., Klebsiella pneumoniae and Streptococcus pneumoniae).Overall, PIP-18[59-76] possessed higher antimicrobial activity than that of chloramphenicol (CHL), ceftazidime (CF) and streptomycin (ST) (30 µg/disc). When the two most active peptides, PIP-18[59-76] and ß-Asp65-PIP[59-67], were applied topically at a 150 mg/kg dose for testing wound healing activity in a mouse model of S. aureus infection, the former accelerates faster wound healing than the latter peptide at 14 days post-treatment. The western blot data suggest that the topical application of peptides (PIP-18[59-67] and ß-Asp65-PIP[59-67]) modulates NF-kB mediated wound repair in mice with relatively little haemolytic (100-1.56 µg/ml) and cytotoxic (1000-3.125 µg/ml) effects evident on human cells in vitro.

dc.publisherElsevier
dc.titleNovel phospholipase A2 inhibitors from python serum are potent peptide antibiotics
dc.typeJournal Article
dcterms.source.volume111
dcterms.source.startPage30
dcterms.source.endPage44
dcterms.source.issn0300-9084
dcterms.source.titleBiochimie
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record